Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

BPC records net income of $7.59 million in 9M 2017


According to the financial statements of  Birzeit  Pharmaceuticals BPC for the first nine months of 2018, Net profit after tax of the period reached 7,588,710 USD Compared with Net profit after tax 8,348,350 USD for 2017, a net decrease in profit of 9.10%.Total assets of the company reached 86,547,277 USD compared with total assets of 80,644,765 USD at the end of year 2017, a net increase of 7.32%.Total liabilities of the company reached 14,383,531 USD compared with total liabilities of 12,133,373 USD at the end of year 2017, a net increase of 18.54%. Net ownership equity of the company reached 72,163,746 USD (Including Non-Controlling Interests of 633,943 USD) compared with total owner equity of 68,511,392 USD (Including Non-Controlling Interests of 521,788 USD) at the end of year 2017, a net increase of 5.33%.Noting that paid-in capital increased from 18,502,825 USD in year 2017 to 19,002,401 USD of this year,a net increase of 2.70%



RSR posts net income of JD0.31 million in 9M 2021

APC records net income of JD0.82 million in 9M 2021

ARAB posts net income of JD0.02 million in 9M 2021

Al-Quds Index in a narrow range amid an increase in 9M financial data disclosures anticipation

PHARMACARE recommends distributing 10% cash dividends for the year 2020

A transaction on the stocks of TRSUT raises the trading value in the PEX

Al-Quds Index rebounds upwards in the first week of October



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013